Golubicić I, Jelić-Radosević Lj, Sobić V
Srp Arh Celok Lek. 1994 Jan-Feb;122(1-2):24-6.
Significant improvement in survival of patients treated for testicular seminoma, particularly in early stages of disease, shows that combined treatment can cause both acute reactions and/or late adverse effects in some cases. These rare complications may have great impact on quality of life of long-term survivors. The aim of our investigation was to assess incidence and intensity of sequelae in a group of 113 patients receiving postoperative radiotherapy for testicular seminoma stage I and II over the period 1982-1988, as well as to determine possible risk-factors. The follow-up period was 24-84 months (Me = 68.4 m). Acute symptoms were noticed in 19.4% of patients, all of them being of a mild degree and no case required a delay of treatment. Long-term complications developed in 8.8% of patients. During the follow-up period two secondary cancers were detected and histologically proved. These results are acceptable and similar to other published data, and in relation to the good prognosis with combined treatment, it can be concluded that the infradiaphragmatic radiotherapy is the obliged part of management for testicular seminoma in early stages.
睾丸精原细胞瘤患者的生存率有显著提高,尤其是在疾病早期,这表明联合治疗在某些情况下可能会引发急性反应和/或晚期不良反应。这些罕见的并发症可能会对长期幸存者的生活质量产生重大影响。我们研究的目的是评估1982年至1988年间接受I期和II期睾丸精原细胞瘤术后放疗的113例患者的后遗症发生率和严重程度,并确定可能的风险因素。随访期为24至84个月(中位数=68.4个月)。19.4%的患者出现急性症状,均为轻度,无一例需要推迟治疗。8.8%的患者出现长期并发症。在随访期间,检测到并经组织学证实有两例继发性癌症。这些结果是可以接受的,与其他已发表的数据相似,并且鉴于联合治疗的良好预后,可以得出结论,膈下放疗是早期睾丸精原细胞瘤治疗中必不可少的一部分。